Following spatial Aβ aggregation dynamics in evolving Alzheimer's disease pathology by imaging stable isotope labeling kinetics.
Wojciech MichnoKatie M StringerEnzlein ThomasMelissa K PassarelliStéphane EscrigKarina S VitanovaJack WoodKaj BlennowHenrik ZetterbergAnders MeibomCarsten HopfFrances A EdwardsJörg HanriederPublished in: Science advances (2021)
β-Amyloid (Aβ) plaque formation is the major pathological hallmark of Alzheimer's disease (AD) and constitutes a potentially critical, early inducer driving AD pathogenesis as it precedes other pathological events and cognitive symptoms by decades. It is therefore critical to understand how Aβ pathology is initiated and where and when distinct Aβ species aggregate. Here, we used metabolic isotope labeling in APPNL-G-F knock-in mice together with mass spectrometry imaging to monitor the earliest seeds of Aβ deposition through ongoing plaque development. This allowed visualizing Aβ aggregation dynamics within single plaques across different brain regions. We show that formation of structurally distinct plaques is associated with differential Aβ peptide deposition. Specifically, Aβ1-42 is forming an initial core structure followed by radial outgrowth and late secretion and deposition of Aβ1-38. These data describe a detailed picture of the earliest events of precipitating amyloid pathology at scales not previously possible.
Keyphrases
- high resolution
- mass spectrometry
- coronary artery disease
- cognitive decline
- gas chromatography
- liquid chromatography
- type diabetes
- white matter
- metabolic syndrome
- high fat diet induced
- high performance liquid chromatography
- capillary electrophoresis
- brain injury
- ultrasound guided
- insulin resistance
- sleep quality
- functional connectivity
- physical activity
- data analysis
- fluorescent probe